What We're Reading: Page 134
Industry reads hand-picked by our editors
Feb 01, 2022
Jan 31, 2022
-
The Boston Globe
In the region’s booming biotech industry, workers are in short supply
-
The Wall Street Journal
Drugmakers Raised Prices by 6.6% on Average Early This Year
-
Reuters
Merck's COVID pill is last choice for U.S. patients, global use varies
Jan 28, 2022
Jan 27, 2022
-
The Boston Globe
Massachusetts biopharma firms raised a record $13.7 billion in venture capital last year
-
Financial Times
GSK kicks off trials of pioneering 'bioelectronic' disease treatment
-
STAT
Early research suggests cancer drug could help flush HIV from its hiding spots
-
Fortune
How Novavax's COVID vaccine gained a cult-like following before US approval
Jan 26, 2022
Jan 25, 2022
-
Bloomberg Law
Califf on Path to Win FDA Chief Role Despite Expected 'No' Votes
-
The Washington Post
FDA ends for now use of two monoclonal antibodies, spurring a halt in federal shipments of the Covid-19 treatments
-
Axios
Mark Cuban launches digital pharmacy promising steep discounts on generic drugs
-
The Atlantic
How a Rare Brain Mutation Spread Across America
Jan 24, 2022
-
Dallas News
Mark Cuban’s online pharmacy is now open with low-cost prescription drugs
-
STAT
Did veteran drug developer Hal Barron accomplish his mission at GSK?
-
Chemical & Engineering News
Many of our proteins remain hidden in the dark proteome
-
The New York Times
How Omicron Is Different Than Delta
Previous
